FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vassiliki Papadimitrakopoulou

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Erminia Massarelli; Heidi S Erickson; Faye M Johnson; Ignacio I Wistuba; Vassiliki A Papadimitrakopoulou
Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance.
William N William; Vassiliki A Papadimitrakopoulou
Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.
William N William; Ignacio I Wistuba; Arlene M Correa; Jeremy J Erasmus; Kathryn A Gold; John Heymach; Neda Kalhor; Edward S Kim; J Jack Lee; Reginald F Munden; Vassiliki A Papadimitrakopoulou; Abujiang Pataer; David C Rice; Stephen G Swisher
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vassiliki Papadimitrakopoulou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Erminia Massarelli; Heidi S Erickson; Faye M Johnson; Ignacio I Wistuba; Vassiliki A Papadimitrakopoulou
Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance.
Lung cancer (Amsterdam, Netherlands) 2013;80(3):235-41.
2013: William N William; Vassiliki A Papadimitrakopoulou
Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.
Cancer prevention research (Philadelphia, Pa.) 2013;6(5):375-8.
2013: William N William; Ignacio I Wistuba; Arlene M Correa; Jeremy J Erasmus; Kathryn A Gold; John Heymach; Neda Kalhor; Edward S Kim; J Jack Lee; Reginald F Munden; Vassiliki A Papadimitrakopoulou; Abujiang Pataer; David C Rice; Stephen G Swisher
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(2):222-8.
2012: Erminia Massarelli; Vassiliki A Papadimitrakopoulou
Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(16 Suppl 5):S379-82.
2012: Vassiliki A Papadimitrakopoulou; Jean-Charles Soria; Annette Jappe; Valentine Jehl; Judith Klimovsky; Bruce E Johnson
Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(10):1594-601.
2012: Vassiliki A Papadimitrakopoulou
Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(8):1315-26.
2012: Nathan T Ihle; Edward S Kim; Jill E Larsen; J Jack Lee; Scott M Lippman; Suyu Liu; John D Minna; Vassiliki A Papadimitrakopoulou; Mena F Abdelmelek; George R Blumenschein; Lauren A Byers; Lu Chen; Kevin R Coombes; Lixia Diao; Roy S Herbst; John V Heymach; Waun K Hong; Pierre Saintigny; Ximing Tang; Anne Tsao; Jing Wang; Ignacio I Wistuba; Shuxing Zhang; Garth Powis
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.
Journal of the National Cancer Institute 2012;104(3):228-39.
2011: Anne S Tsao; Ignacio I Wistuba; Hai T Tran; George R Blumenschein; Chusilp Charnsangavej; Frank V Fossella; Junya Fujimoto; Waun K Hong; Merrill S Kies; J Jack Lee; Suyu Liu; Edith M Marom; Vassiliki A Papadimitrakopoulou; David J Stewart
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(12):2104-11.
2011: Anne S Tsao; Vassiliki A Papadimitrakopoulou
Mitotic inhibitors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(11 Suppl 4):S1789-90.
2011: Anne S Tsao; Vassiliki A Papadimitrakopoulou
The future of NSCLC: molecular profiles guiding treatment decisions.
Oncology (Williston Park, N.Y.) 2011;25(7):607, 614.
2011: Hai T Tran; Ralph G Zinner; George R Blumenschein; Yun W Oh; Vassiliki A Papadimitrakopoulou; Edward S Kim; Charles Lu; Mubashira Malik; Bert L Lum; Roy S Herbst
Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC).
Investigational new drugs 2011;29(3):499-505.
2011: Heather D Brooks; Bonnie S Glisson; B Nebiyou Bekele; Lawrence E Ginsberg; Adel El-Naggar; Kirk S Culotta; Naoko Takebe; John Wright; Hai T Tran; Faye M Johnson; Vassiliki A Papadimitrakopoulou
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
Cancer 2011;117(10):2112-9.
2011: Daisuke Sano; Fumihiko Matsumoto; David R Valdecanas; Mei Zhao; David P Molkentine; Yoko Takahashi; Ehab Y Hanna; Vassiliki A Papadimitrakopoulou; John V Heymach; Luka Milas; Jeffrey N Myers
Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1815-27.
2011: Pierre Saintigny; Li Zhang; You-Hong Fan; Adel K El-Naggar; Vassiliki A Papadimitrakopoulou; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Li Mao
Gene expression profiling predicts the development of oral cancer.
Cancer prevention research (Philadelphia, Pa.) 2011;4(2):218-29.
2010: Lauren Averett Byers; F Christopher Holsinger; Merrill S Kies; William N William; Adel K El-Naggar; J Jack Lee; Jianhua Hu; Adriana Lopez; Hai T Tran; Shaoyu Yan; Zhiqiang Du; K Kian Ang; Bonnie S Glisson; Maria Gabriela Raso; Ignacio I Wistuba; Jeffrey N Myers; Waun Ki Hong; Vassiliki A Papadimitrakopoulou; Scott M Lippman; John V Heymach
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer.
Molecular cancer therapeutics 2010;9(6):1755-63.
2010: Gokcen Yildirim; William H Morrison; David I Rosenthal; Erich M Sturgis; Vassiliki A Papadimitrakopoulou; David L Schwartz; Adam S Garden
Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy.
Head & neck 2010;32(4):473-80.
2010: Jieru Meng; Bingbing Dai; Bingliang Fang; B Nebiyou Bekele; William G Bornmann; Duoli Sun; Zhenghong Peng; Roy S Herbst; Vassiliki A Papadimitrakopoulou; John D Minna; Michael Peyton; Jack A Roth
Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
PloS one 2010;5(11):e14124.
2010: Merrill S Kies; F Christopher Holsinger; J Jack Lee; William N William; Bonnie S Glisson; Heather Y Lin; Jan S Lewin; Lawrence E Ginsberg; Katharine A Gillaspy; Erminia Massarelli; Lauren Byers; Scott M Lippman; Waun K Hong; Adel K El-Naggar; Adam S Garden; Vassiliki A Papadimitrakopoulou
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):8-14.
2009: Anne S Tsao; Diane Liu; Jack Martin; Xi-ming Tang; J Jack Lee; Adel K El-Naggar; Ignacio I Wistuba; Kirk S Culotta; Li Mao; Ann M Gillenwater; Yuko M Sagesaka; Waun K Hong; Vassiliki A Papadimitrakopoulou
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
Cancer prevention research (Philadelphia, Pa.) 2009;2(11):931-41.
2009: Pierre Saintigny; Adel K El-Naggar; Vassiliki A Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6284-91.
2009: Nabil Saba; Misun Choi; Susan Muller; Hyung Ju C Shin; Mourad Tighiouart; Vassiliki A Papadimitrakopoulou; Adel K El-Naggar; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
Cancer prevention research (Philadelphia, Pa.) 2009;2(9):823-9.
2009: Vassiliki A Papadimitrakopoulou; J Jack Lee; William N William; Jack W Martin; Margaret Thomas; Edward S Kim; Fadlo R Khuri; Dong M Shin; Lei Feng; Waun Ki Hong; Scott M Lippman
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):599-604.
2009: William N William; J Jack Lee; Scott M Lippman; Jack W Martin; Nitin Chakravarti; Hai T Tran; Anita L Sabichi; Edward S Kim; Lei Feng; Reuben Lotan; Vassiliki A Papadimitrakopoulou
High-dose fenretinide in oral leukoplakia.
Cancer prevention research (Philadelphia, Pa.) 2009;2(1):22-6.
2009: Vassiliki A Papadimitrakopoulou; Julie G Izzo; Diane D Liu; Jeffrey L Myers; Tania L Ceron; Jan Lewin; William N William; Anthea Atwell; J Jack Lee; Ann M Gillenwater; Adel El-Naggar; Xifeng Wu; Scott M Lippman; Walter N Hittelman; Waun Ki Hong
Cyclin D1 and cancer development in laryngeal premalignancy patients.
Cancer prevention research (Philadelphia, Pa.) 2009;2(1):14-21.
2008: Vassiliki A Papadimitrakopoulou; William N William; Andrew J Dannenberg; Scott M Lippman; J Jack Lee; Frank G Ondrey; Douglas E Peterson; Lei Feng; Anthea Atwell; Adel K El-Naggar; Cherie-Ann Nathan; Joseph I Helman; Baoheng Du; Bevan Yueh; Jay O Boyle
Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2095-101.
2008: George R Blumenschein; Merrill S Kies; Vassiliki A Papadimitrakopoulou; Charles Lu; Ashok J Kumar; Justin L Ricker; Judy H Chiao; Cong Chen; Stanley R Frankel
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
Investigational new drugs 2008;26(1):81-7.
2008: Hidetoshi Kawaguchi; Adel K El-Naggar; Vassiliki A Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):354-60.
2007: Ian J Bristol; Anesa Ahamad; Adam S Garden; William H Morrison; Ehab Y Hanna; Vassiliki A Papadimitrakopoulou; David I Rosenthal; K. Kian Ang
Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment.
International journal of radiation oncology, biology, physics 2007;68(3):719-30.
2006: Vassiliki A Papadimitrakopoulou; Alex A. Adjei
The Akt/mTOR and mitogen-activated protein kinase pathways in lung cancer therapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(7):749-51.
2006: Anne S Tsao; Adam S Garden; Merrill S Kies; William Morrison; Lei Feng; J Jack Lee; Fadlo R Khuri; Ralph G Zinner; Jeffery Myers; Vassiliki A Papadimitrakopoulou; Jan Lewin; Gary L Clayman; K. Kian Ang; Bonnie S Glisson
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4163-9.
2006: Vassiliki A Papadimitrakopoulou; Erika N Brown; Diane D Liu; Adel K El-Naggar; J Jack Lee; Waun Ki Hong; Ho-Young Lee
The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
Cancer letters 2006;239(1):136-43.
2006: John V Heymach; Monique Nilsson; George R Blumenschein; Vassiliki A Papadimitrakopoulou; Roy Herbst
Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 2):4441s-4445s.
2006: Scott M Lippman; J Jack Lee; Jack W Martin; Adel K El-Naggar; Xiaochun Xu; Dong M Shin; Margaret Thomas; Li Mao; Herbert A Fritsche; Xian Zhou; Vassiliki A Papadimitrakopoulou; Fadlo R Khuri; Hai Tran; Gary L Clayman; Walter N Hittelman; Waun Ki Hong; Reuben Lotan
Fenretinide activity in retinoid-resistant oral leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3109-14.
2006: Ann M Gillenwater; Vassiliki A Papadimitrakopoulou; Rebecca Richards-Kortum
Oral premalignancy: new methods of detection and treatment.
Current oncology reports 2006;8(2):146-54.
2005: Ralph G Zinner; Frank V Fossella; Gregory W Gladish; Bonnie S Glisson; George R Blumenschein; Vassiliki A Papadimitrakopoulou; Katherine M W Pisters; Edward S Kim; Yun W Oh; Beverly O Peeples; Zhishen Ye; Rafael E Curiel; Coleman K Obasaju; Waun Ki Hong; Roy S Herbst
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
Cancer 2005;104(11):2449-56.
2005: Erminia Massarelli; Diane D Liu; J Jack Lee; Adel K El-Naggar; Lorenzo Lo Muzio; stefania staibano; Sabino De Placido; Jeffrey N Myers; Vassiliki A Papadimitrakopoulou
Akt activation correlates with adverse outcome in tongue cancer.
Cancer 2005;104(11):2430-6.
2005: Faye M Johnson; Adam S Garden; J Lynn Palmer; Dong M Shin; William Morrison; Vassiliki A Papadimitrakopoulou; Fadlo R Khuri; Gary L Clayman; Helmuth Goepfert; K. Kian Ang; Waun Ki Hong; Bonnie S Glisson
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
International journal of radiation oncology, biology, physics 2005;63(3):717-24.
2005: Ho-Young Lee; Seung-Hyun Oh; Young-Ah Suh; Jin Hyen Baek; Vassiliki A Papadimitrakopoulou; Suyun Huang; Waun Ki Hong
Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):6065-74.
2005: Edward S Kim; Merrill S Kies; Frank V Fossella; Bonnie S Glisson; Sara Zaknoen; Paul Statkevich; Reginald F Munden; Carmen Summey; Katherine M W Pisters; Vassiliki A Papadimitrakopoulou; Mourad Tighiouart; André Rogatko; Fadlo R Khuri
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
Cancer 2005;104(3):561-9.
2005: Vassiliki A Papadimitrakopoulou; Sofia Agelaki; Hai T Tran; Merrill S Kies; Robert Gagel; Ralph G Zinner; Edward Kim; Gregory D Ayers; John Wright; Fadlo R Khuri
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4151-9.
2005: Erminia Massarelli; Erika Brown; Ngoc K Tran; Diane D Liu; Julie G Izzo; J Jack Lee; Adel K El-Naggar; Waun Ki Hong; Vassiliki A Papadimitrakopoulou
Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis.
Cancer 2005;103(5):952-9.
2004: Hai T Tran; George R Blumenschein; Charles Lu; Christina A Meyers; Vassiliki A Papadimitrakopoulou; Frank V Fossella; Ralph G Zinner; Timothy Madden; Lori G Smythe; Vinay K Puduvalli; Reginald F Munden; Mylene T Truong; Roy S Herbst
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.
Cancer chemotherapy and pharmacology 2004;54(4):308-14.
2004: Fadlo R Khuri; Bonnie S Glisson; Edward S Kim; Paul Statkevich; Peter F Thall; Michael L Meyers; Roy S Herbst; Reginald F Munden; Craig Tendler; Yali Zhu; Sandra Bangert; Elizabeth Thompson; Charles Lu; Xue-Mei Wang; Dong M Shin; Merrill S Kies; Vassiliki A Papadimitrakopoulou; Frank V Fossella; Paul Kirschmeier; W Robert Bishop; Waun Ki Hong
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2968-76.
2004: Li Mao; Waun Ki Hong; Vassiliki A Papadimitrakopoulou
Focus on head and neck cancer.
Cancer cell 2004;5(4):311-6.
2004: Ritsuko Komaki; Jin Soo Lee; Luka Milas; Hoon K Lee; Frank V Fossella; Roy S Herbst; Pamela K Allen; Zhongxing Liao; Craig W Stevens; Charles Lu; Ralph G Zinner; Vassiliki A Papadimitrakopoulou; Merrill S Kies; George R Blumenschein; Katherine M W Pisters; Bonnie S Glisson; Jonathan M Kurie; Bunyamin Kaplan; Veronica P Garza; Deidre Mooring; Susan L Tucker; James D Cox
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
International journal of radiation oncology, biology, physics 2004;58(5):1369-77.
2004: James L Mulshine; Jane C Atkinson; Robert O Greer; Vassiliki A Papadimitrakopoulou; Carter Van Waes; Susan F Rudy; Jack W Martin; Seth M Steinberg; David J Liewehr; Ingalill Avis; R Ilona Linnoila; Stephen Hewitt; Scott M Lippman; Robin Frye; Paul F Cavanaugh
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1565-73.
2004: Faye M Johnson; Adam Garden; J Lynn Palmer; Merrill S Kies; Gary L Clayman; Brenda Brumfield; Fadlo R Khuri; William Morrison; Vassiliki A Papadimitrakopoulou; Eduardo M Diaz; Bonnie S Glisson
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
Cancer 2004;100(5):991-8.
2003: Charles Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kerstin M Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4546-52.
2003: Vassiliki A Papadimitrakopoulou; Lawrence E Ginsberg; Adam S Garden; Merrill S Kies; Bonnie S Glisson; Eduardo M Diaz; Gary L Clayman; William H Morrison; Diane D Liu; George R Blumenschein; Scott M Lippman; Donald Schommer; Ann M Gillenwater; Helmuth Goepfert; Waun Ki Hong
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Cancer 2003;98(10):2214-23.
2003: Faye M Johnson; Jonathan M Kurie; Beverly O Peeples; J Jack Lee; Lei Feng; Katherine M W Pisters; Frank V Fossella; Vassiliki A Papadimitrakopoulou; George R Blumenschein; Ritsuko Komaki; Bonnie S Glisson
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
Clinical lung cancer 2003;5(1):40-5.
2003: Faye M Johnson; Jonathan M Kurie; Beverly O Peeples; Katherine M W Pisters; Frank V Fossella; Vassiliki A Papadimitrakopoulou; George R Blumenschein; Ritsuko Komaki; Bonnie S Glisson
Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2003;17(7 Suppl 7):17-21.
2003: Katrina Y Glover; Vassiliki A Papadimitrakopoulou
Chemoprevention of head and neck cancer.
Current oncology reports 2003;5(2):152-7.
2003: Julie G Izzo; Vassiliki A Papadimitrakopoulou; Diane D Liu; Petra L C den Hollander; Ilona M Babenko; Jamie Keck; Adel K El-Naggar; Dong M Shin; J Jack Lee; Waun Ki Hong; Walter N Hittelman
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
Journal of the National Cancer Institute 2003;95(3):198-205.
2002: Vassiliki A Papadimitrakopoulou; Diane D Liu; Li Mao; Dong M Shin; Adel El-Naggar; Heladio Ibarguen; J Jack Lee; Waun Ki Hong; Walter N Hittelman
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(12):1605-10.
2002: Roy S Herbst; Fadlo R Khuri; Charles Lu; Diane D Liu; Frank V Fossella; Bonnie S Glisson; Katherine M W Pisters; Dong M Shin; Vassiliki A Papadimitrakopoulou; Jonathan M Kurie; George R Blumenschein; Merrill S Kies; Ralph G Zinner; Maria S Jung; Robert Lu; J Jack Lee; Reginald F Munden; Waun Ki Hong; Jin Soo Lee
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Cancer 2002;95(2):340-53.
2002: Dong M Shin; Bonnie S Glisson; Fadlo R Khuri; Scott M Lippman; Lawrence E Ginsberg; Edward Diaz; Vassiliki A Papadimitrakopoulou; Lei Feng; Marites Francisco; Adam Garden; Merrill S Kies; Jeffrey L Myers; Gary L Clayman; Waun Ki Hong
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Cancer 2002;95(2):322-30.
2002: Vassiliki A Papadimitrakopoulou
Chemoprevention of head and neck cancer: an update.
Current opinion in oncology 2002;14(3):318-22.
2002: Joyce A O'Shaughnessy; Gary J Kelloff; Gary B Gordon; Andrew J Dannenberg; Waun Ki Hong; Carol J Fabian; Caroline C Sigman; Monica M Bertagnolli; Steven P Stratton; Stephen Lam; William G Nelson; Frank L Meyskens; David S Alberts; Michele Follen; Anil K Rustgi; Vassiliki A Papadimitrakopoulou; Peter T Scardino; Adi F Gazdar; Lee W Wattenberg; Michael B. Sporn; Wael A Sakr; Scott M Lippman; Daniel Von Hoff
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):314-46.
2002: Ritsuko Komaki; Jin S Lee; Bunyamin Kaplan; P Allen; Jason F Kelly; Zhongxing Liao; Craig W Stevens; Frank V Fossella; Ralph G Zinner; Vassiliki A Papadimitrakopoulou; Fadlo R Khuri; Bonnie S Glisson; Katherine M W Pisters; Jonathan M Kurie; Roy Herbst; Luka Milas; Jae Y Ro; H D Thames; Waun Ki Hong; James D Cox
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Seminars in radiation oncology 2002;12(1 Suppl 1):46-9.
2001: Vassiliki A Papadimitrakopoulou; Julie G Izzo; Li Mao; J Keck; D Hamilton; Dong M Shin; Adel El-Naggar; P den Hollander; Diane Liu; Walter N Hittelman; Waun Ki Hong
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3127-34.
2001: Dong M Shin; Fadlo R Khuri; B Murphy; Adam S Garden; Gary L Clayman; M Francisco; Diane Liu; Bonnie S Glisson; Lawrence E Ginsberg; Vassiliki A Papadimitrakopoulou; Jeffrey L Myers; William Morrison; Ann M Gillenwater; K. Kian Ang; Scott M Lippman; Helmuth Goepfert; Waun Ki Hong
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3010-7.
2001: Jean-Charles Soria; J Izzo; Li Mao; Waun Ki Hong; Vassiliki A Papadimitrakopoulou
[Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention].
Bulletin du cancer 2001;88(4):351-61.
2000: Vassiliki A Papadimitrakopoulou; Waun Ki Hong
Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer.
International journal of cancer. Journal international du cancer 2000;88(6):852-5.
2000: Vassiliki A Papadimitrakopoulou
Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal.
Current opinion in oncology 2000;12(3):240-5.
1999: Vassiliki A Papadimitrakopoulou; Gary L Clayman; Dong M Shin; Jeffrey N Myers; Ann M Gillenwater; Helmuth Goepfert; Adel K El-Naggar; Jan S Lewin; Scott M Lippman; Waun Ki Hong
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Archives of otolaryngology--head & neck surgery 1999;125(10):1083-9.
1999: Vassiliki A Papadimitrakopoulou; Waun Ki Hong
Combined-modality therapy in paranasal sinus cancer.
The cancer journal from Scientific American 1999;5(4):208-10.
1998: Julie G Izzo; Vassiliki A Papadimitrakopoulou; X Q Li; Heladio Ibarguen; Jin S Lee; Jae Y Ro; Adel El-Naggar; Waun Ki Hong; Walter N Hittelman
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Oncogene 1998;17(18):2313-22.
1998: Li Mao; Adel K El-Naggar; Vassiliki A Papadimitrakopoulou; Dong M Shin; H C Shin; Y Fan; Xinhui Zhou; Gary L Clayman; J Jack Lee; Jin S Lee; Walter N Hittelman; Scott M Lippman; Waun Ki Hong
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
Journal of the National Cancer Institute 1998;90(20):1545-51.
1998: C Geyer; Vassiliki A Papadimitrakopoulou; Waun Ki Hong
Chemoprevention in head and neck cancer: basic science and clinical application.
Seminars in radiation oncology 1998;8(4):292-301.
1998: Dong M Shin; Bonnie S Glisson; Fadlo R Khuri; Lawrence E Ginsberg; Vassiliki A Papadimitrakopoulou; J Jack Lee; KN Lawhorn; Ann M Gillenwater; K. Kian Ang; Gary L Clayman; David L Callender; Waun Ki Hong; Scott M Lippman
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1325-30.
1998: Vassiliki A Papadimitrakopoulou; Yun Oh; Adel El-Naggar; Julie G Izzo; Gary L Clayman; Li Mao
Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):539-44.
1997: Vassiliki A Papadimitrakopoulou; Waun Ki Hong
Retinoids in head and neck chemoprevention.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1997;216(2):283-90.
1997: Vassiliki A Papadimitrakopoulou; Julie G Izzo; Scott M Lippman; Jin S Lee; You-Hong Fan; Gary L Clayman; Jae Y Ro; Walter N Hittelman; Reuben Lotan; Waun Ki Hong; Li Mao
Frequent inactivation of p16INK4a in oral premalignant lesions.
Oncogene 1997;14(15):1799-803.
1997: Vassiliki A Papadimitrakopoulou; I W Dimery; J J Lee; C Perez; Waun Ki Hong; S M Lippman
Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
The cancer journal from Scientific American 1997;3(2):92-9.
1997: Vassiliki A Papadimitrakopoulou; Waun Ki Hong; Jin S Lee; Jack W Martin; J Jack Lee; John G Batsakis; Scott M Lippman
Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.
Journal of the National Cancer Institute 1997;89(3):257-8.
1996: Vassiliki A Papadimitrakopoulou; Waun Ki Hong
Biology of oral premalignant lesions: concepts and implications for chemoprevention.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1996;5 Suppl 2():87-93.
1996: S K Kim; Y Fan; Vassiliki A Papadimitrakopoulou; Gary L Clayman; Walter N Hittelman; Waun Ki Hong; Reuben Lotan; Li Mao
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
Cancer research 1996;56(11):2519-21.
1996: Vassiliki A Papadimitrakopoulou; Dong M Shin; Waun Ki Hong
Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.
Cancer metastasis reviews 1996;15(1):53-76.